Clinical Trials Logo

Clinical Trial Summary

Attentional disorders have been reported in neuropsychological studies evaluating patients suffering from generalized idiopathic epilepsy, but the data are disparate (in terms of test protocol). We aim to describe attentional and executive function disorder in IGE thanks to the Epitrack scale, validated in this specific population. Our secondary objective is to study the dynamic of cortical activity during an attentional task (the ANT), in order to describe the alteration of cortical networks in epileptic patients presenting with attentional disturbance.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05530109
Study type Observational
Source University Hospital, Lille
Contact Philippe DERAMBURE, MD,PhD
Phone 0320445962
Email philippe.derambure@chru-lille.fr
Status Recruiting
Phase
Start date April 26, 2022
Completion date April 2025

See also
  Status Clinical Trial Phase
Completed NCT01432821 - Blinking and Yawning in Epilepsy: The Role of Dopamine N/A
Recruiting NCT05374928 - Human Epilepsy Project 3
Completed NCT04252846 - A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy
Active, not recruiting NCT05147571 - RNS System NAUTILUS Study Phase 3